← United States · Coverage record
US · SEC FORM 4
Day One Biopharmaceuticals, Inc.
DAWN · — · CIK 0001845337 · Healthcare
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
14 Form 4 transaction lines observed in the same window
0 sales · 14 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-10-20 · ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day1 LLC; Access Industries Holdings LLC; Blavatnik Len.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
The FINRA report lists no short interest for this ticker.
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2023-10-20 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day1 LLC; Access Industries Holdings LLC; Blavatnik Len | Purchase (P) | Common Stock | 111,387 | USD 9.97 | USD 1,110,528 | SEC filing ↗ |
| 2023-10-19 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day1 LLC; Access Industries Holdings LLC; Blavatnik Len | Purchase (P) | Common Stock | 384,400 | USD 10.06 | USD 3,867,064 | SEC filing ↗ |
| 2023-10-18 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day1 LLC; Access Industries Holdings LLC; Blavatnik Len | Purchase (P) | Common Stock | 979,667 | USD 10.21 | USD 10,002,400 | SEC filing ↗ |
| 2023-06-09 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day1 LLC; Access Industries Holdings LLC; Blavatnik Len | Purchase (P) | Common Stock | 769,230 | USD 13.00 | USD 9,999,990 | SEC filing ↗ |
| 2022-06-17 | Gladstone Michael | Purchase (P) | Common Stock | 766,667 | USD 15.00 | USD 11,500,005 | SEC filing ↗ |
| 2022-06-17 | Atlas Venture Associates Opportunity I, L.P.; Atlas Venture Associates Opportunity I, LLC; Atlas Venture Associates XI, L.P.; Atlas Venture Associates XI, LLC; Atlas Venture Fund XI, L.P.; Atlas Venture Opportunity Fund I, L.P.; Atlas Venture Opportunity Fund II, L.P. | Purchase (P) | Common Stock | 766,667 | USD 15.00 | USD 11,500,005 | SEC filing ↗ |
| 2022-06-17 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day1 LLC; Access Industries Holdings LLC; Blavatnik Len | Purchase (P) | Common Stock | 1,200,000 | USD 15.00 | USD 18,000,000 | SEC filing ↗ |
| 2022-01-20 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day1 LLC; Access Industries Holdings LLC; Blavatnik Len | Purchase (P) | Common Stock | 4,615 | USD 14.73 | USD 67,979 | SEC filing ↗ |
| 2022-01-19 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day1 LLC; Access Industries Holdings LLC; Blavatnik Len | Purchase (P) | Common Stock | 58,818 | USD 14.70 | USD 864,625 | SEC filing ↗ |
| 2022-01-18 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day1 LLC; Access Industries Holdings LLC; Blavatnik Len | Purchase (P) | Common Stock | 43,429 | USD 14.26 | USD 619,298 | SEC filing ↗ |
| 2021-06-01 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day 1 LLC; Access Industries Holdings LLC; Blavatnik Len | Purchase (P) | Common Stock | 875,000 | USD 16.00 | USD 14,000,000 | SEC filing ↗ |
| 2021-06-01 | Grant Papanek Julie | Purchase (P) | Common Stock | 13,000 | USD 16.00 | USD 208,000 | SEC filing ↗ |
| 2021-06-01 | Canaan Partners XI LLC; Canaan XI L.P. | Purchase (P) | Common Stock | 13,000 | USD 16.00 | USD 208,000 | SEC filing ↗ |
| 2021-06-01 | Atlas Venture Associates Opportunity I, L.P.; Atlas Venture Associates Opportunity I, LLC; Atlas Venture Associates XI, L.P.; Atlas Venture Associates XI, LLC; Atlas Venture Fund XI, L.P.; Atlas Venture Opportunity Fund I, L.P. | Purchase (P) | Common Stock | 250,000 | USD 16.00 | USD 4,000,000 | SEC filing ↗ |
| 2021-06-01 | Josey John A. | Purchase (P) | Common Stock | 7,000 | USD 16.00 | USD 112,000 | SEC filing ↗ |
Form 4 evidence
53 transaction lines in the latest 365-day window; 384 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day1 LLC; Access Industries Holdings LLC; Blavatnik Len | U (U) | Common Stock | 12,929,322 | USD 21.50 | USD 277,980,423 | SEC filing ↗ |
| 2026-04-23 | York Charles N II | D (D) | Common Stock | 312,025 | USD — | USD — | SEC filing ↗ |
| 2026-04-23 | VASCONCELLES MICHAEL | D (D) | Common Stock | 4,397 | USD — | USD — | SEC filing ↗ |
Show recent Form 4 evidence (28 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | ACCESS INDUSTRIES MANAGEMENT, LLC; AI Day1 LLC; Access Industries Holdings LLC; Blavatnik Len | U (U) | Common Stock | 12,929,322 | USD 21.50 | USD 277,980,423 | SEC filing ↗ |
| 2026-04-23 | York Charles N II | D (D) | Common Stock | 312,025 | USD — | USD — | SEC filing ↗ |
| 2026-04-23 | VASCONCELLES MICHAEL | D (D) | Common Stock | 4,397 | USD — | USD — | SEC filing ↗ |
| 2026-04-23 | Ramasastry Saira | D (D) | Common Stock | 40,485 | USD — | USD — | SEC filing ↗ |
| 2026-04-23 | Merendino Lauren | D (D) | Common Stock | 60,157 | USD — | USD — | SEC filing ↗ |
| 2026-04-23 | Josey John A. | D (D) | Common Stock | 72,292 | USD — | USD — | SEC filing ↗ |
| 2026-04-23 | Holles Natalie C. | D (D) | Common Stock | 57,310 | USD — | USD — | SEC filing ↗ |
| 2026-04-23 | Dubow Adam | D (D) | Common Stock | 72,694 | USD — | USD — | SEC filing ↗ |
| 2026-04-23 | Bender Jeremy | D (D) | Common Stock | 1,499,031 | USD — | USD — | SEC filing ↗ |
| 2026-02-17 | York Charles N II | Sale (S) | Common Stock | 6,065 | USD 11.60 | USD 70,354 | SEC filing ↗ |
| 2026-02-17 | VASCONCELLES MICHAEL | Sale (S) | Common Stock | 2,728 | USD 11.60 | USD 31,645 | SEC filing ↗ |
| 2026-02-17 | Merendino Lauren | Sale (S) | Common Stock | 5,814 | USD 11.60 | USD 67,442 | SEC filing ↗ |
| 2026-02-17 | Dubow Adam | Sale (S) | Common Stock | 6,395 | USD 11.60 | USD 74,182 | SEC filing ↗ |
| 2026-02-17 | Bender Jeremy | Sale (S) | Common Stock | 15,459 | USD 11.60 | USD 179,324 | SEC filing ↗ |
| 2026-02-15 | York Charles N II | Option exercise / conversion (M) | Common Stock | 16,750 | USD — | USD — | SEC filing ↗ |
| 2026-02-15 | VASCONCELLES MICHAEL | Option exercise / conversion (M) | Common Stock | 7,125 | USD — | USD — | SEC filing ↗ |
| 2026-02-15 | Merendino Lauren | Option exercise / conversion (M) | Common Stock | 15,162 | USD — | USD — | SEC filing ↗ |
| 2026-02-15 | Dubow Adam | Option exercise / conversion (M) | Common Stock | 16,463 | USD — | USD — | SEC filing ↗ |
| 2026-02-15 | Bender Jeremy | Option exercise / conversion (M) | Common Stock | 42,937 | USD — | USD — | SEC filing ↗ |
| 2025-11-25 | Bender Jeremy | Gift (G) | Common Stock | 307,225 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-11-17 | York Charles N II | Sale (S) | Common Stock | 4,062 | USD 8.91 | USD 36,192 | SEC filing ↗ |
| 2025-11-17 | Merendino Lauren | Sale (S) | Common Stock | 3,726 | USD 8.91 | USD 33,199 | SEC filing ↗ |
| 2025-11-17 | Dubow Adam | Sale (S) | Common Stock | 4,319 | USD 8.91 | USD 38,482 | SEC filing ↗ |
| 2025-11-17 | Bender Jeremy | Sale (S) | Common Stock | 15,894 | USD 8.91 | USD 141,616 | SEC filing ↗ |
| 2025-11-15 | York Charles N II | Option exercise / conversion (M) | Common Stock | 10,250 | USD — | USD — | SEC filing ↗ |
| 2025-11-15 | Merendino Lauren | Option exercise / conversion (M) | Common Stock | 6,849 | USD — | USD — | SEC filing ↗ |
| 2025-11-15 | Dubow Adam | Option exercise / conversion (M) | Common Stock | 8,400 | USD — | USD — | SEC filing ↗ |
| 2025-11-15 | Bender Jeremy | Option exercise / conversion (M) | Common Stock | 20,007 | USD — | USD — | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | DAWN |
| CIK | 0001845337 |
| Sector | Healthcare |
| Industry | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | — |
Data coverage
| Local Form 4 history | 384 transaction lines from 2021-06-01 to 2026-04-23 16 P purchase lines · 181 S sale lines · 187 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.